Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Myelodysplastic Syndromes 58Leukemia 56Leukemia, Myeloid, Acute 47Lymphoma 40Precursor Cell Lymphoblastic Leukemia-Lymphoma 37Lymphoma, Non-Hodgkin 35Leukemia, Lymphocytic, Chronic, B-Cell 35Myeloproliferative Disorders 34Multiple Myeloma 31Hodgkin Disease 30Leukemia, Myeloid, Chronic-Phase 28Leukemia, Myeloid, Accelerated Phase 28Lymphoma, Follicular 27Lymphoma, B-Cell, Marginal Zone 27Burkitt Lymphoma 27Lymphoma, Large B-Cell, Diffuse 26Lymphoma, Mantle-Cell 25Neoplasms, Plasma Cell 24Leukemia, Myelomonocytic, Chronic 23Congenital Abnormalities 23Lymphoma, Large-Cell, Immunoblastic 22Myelodysplastic-Myeloproliferative Diseases 20Graft vs Host Disease 20Blast Crisis 20Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 19Anemia, Refractory, with Excess of Blasts 19Primary Myelofibrosis 18Dendritic Cell Sarcoma, Interdigitating 18Recurrence 17Hematologic Neoplasms 16

Interventions

thymoglobulin 1fludarabine phosphate 1fludarabine 1Clofarabine 1Busulfan 1Antilymphocyte Serum 1Alemtuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Metabolic Diseases × Antilymphocyte Serum × Clear all
NCT01135537 2019-11-04

Pharmacokinetics of Thymoglobulin in Paediatric Haematopoietic Stem-cell Transplants

The Hospital for Sick Children

Phase 2 Terminated
30 enrolled 4 charts

Metabolic Diseases, Neoplasms, Genetic Diseases, Inborn

Data powered by HemOnc (CC BY 4.0) Colophon âš¡